Results 1 to 10 of about 23,762 (225)

DHFR (dihydrofolate reductase) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
Dihydrofolate reductase (DHFR) is a member of the reductase enzyme family, which is ubiquitously expressed in all organisms. Levels of this enzyme peak at the G1/S cell cycle boundary. Autoregulation, through DHFR-RNA interactions, has also been reported.
Krajinovic, Maja   +2 more
openaire   +4 more sources

Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana [PDF]

open access: yesMalaria Journal, 2005
Abstract Background Both chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) are failing drugs in much of sub-Saharan Africa. Previous findings suggest an association between resistance to CQ and to SP in vivo, in vitro, and on the molecular level.
Mockenhaupt, F.P.   +6 more
openaire   +9 more sources

Methotrexate-Based PROTACs as DHFR-Specific Chemical Probes

open access: yesCell Chemical Biology
Methotrexate (MTX) is a tight-binding dihydrofolate reductase (DHFR) inhibitor, used as both an antineoplastic and immunosuppressant therapeutic. MTX, like folate undergoes folylpolyglutamate synthetase-mediated γ-glutamylation, which affects cellular retention and target specificity.
Scott K Durum
exaly   +3 more sources

Transfection of DHFR− and DHFR+ mammalian cells using methotrexate‐resistant mutants of mouse dihydrofolate reductase [PDF]

open access: yesFEBS Letters, 1990
Site‐directed mutagenesis was used to generate mutants of mouse dihydrofolate reductase more resistant to methotrexate than the wild type enzyme. The mutant genes were used to transfert either DHFR− or DHFR+ cell lines. These mutants, as well as the wild type gene, were able to confer methotrexate resistance to DHFR− CHO cells.
Thillet, Joëlle, Pictet, Raymond
openaire   +2 more sources

In silico analysis, synthesis and biological evaluation of DHFR inhibitors [PDF]

open access: yesFolia Medica, 2021
Introduction: Malaria is one of the varieties of fatal diseases caused by a protozoan parasite that is now considered to be the greatest global health challenge. A parasite of Plasmodium species triggers it transmitting the disease to humans by the bites of female Anopheles mosquitoes.
Chaitali Lad   +6 more
openaire   +3 more sources

Fingerprinting DHFR in Single-Molecule AFM Studies [PDF]

open access: yesBiophysical Journal, 2006
In a recent issue of the Biophysical Journal, we reported that ligand binding modulated the mechanical stability of Chinese hamster ovary dihydrofolate reductase (DHFR), an enzyme essential for cell survival. In our work, we found that, in the absence of ligands, DHFR displayed low mechanical stability, with an average unfolding force of only 27 pN (1).
Ainavarapu, Sri Rama Koti   +2 more
openaire   +2 more sources

Correlated Motions in the DHFR-NADPH Complex [PDF]

open access: yesBiophysical Journal, 2017
Correlated motions are thought to be related to the catalytic step for dihydrofolate reductase (DHFR). We performed several molecular dynamics studies of the DHFR-NADPH complex, the analog of anapo structure existing prior tothe binding of dihydrofolate.
Craig J. Earley   +4 more
openaire   +1 more source

A genetic polymorphism within the third poly(A) signal of the DHFR gene alters the polyadenylation pattern of DHFR transcripts in CHL cells [PDF]

open access: yesNucleic Acids Research, 1994
Two polymorphic dihydrofolate reductase (DHFR) alleles, termed 20 K and 21 K, exist in Chinese hamster lung cells. Three major transcripts of different lengths are transcribed from each allele, and the expression of these transcripts differs dramatically between the alleles as a result of differential utilization of three poly(A) sites.
Honghao Yang, Peter W. Melera
openaire   +3 more sources

Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR [PDF]

open access: yesRSC Medicinal Chemistry, 2020
P218 is a potent inhibitor of M. ulcerans DHFR ( K i 3.2 nM).
Gustavo Pelicioli Riboldi   +5 more
openaire   +3 more sources

New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells.

open access: yesKlinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2013
Methotrexate, a structural analogue of folic acid, is one of the most frequently used chemotherapeutics, especially in haematological malignancies, various solid tumours and also inflammatory disorders. Methotrexate interferes with folate metabolism, mainly by inhibition of dihydrofolate reductase, resulting in the suppression of purine and pyrimidine ...
J, Neradil, G, Pavlasova, R, Veselska
openaire   +1 more source

Home - About - Disclaimer - Privacy